|
TDRD7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70457999999485E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.557100E-04 |
| Normal-vs-Stage2 |
2.018900E-04 |
| Normal-vs-Stage3 |
5.391200E-04 |
| Normal-vs-Stage4 |
1.022840E-03 |
| Stage1-vs-Stage2 |
9.698300E-02 |
| Stage1-vs-Stage3 |
4.174200E-01 |
| Stage1-vs-Stage4 |
1.505650E-01 |
| Stage2-vs-Stage3 |
3.940400E-01 |
| Stage2-vs-Stage4 |
8.766400E-01 |
| Stage3-vs-Stage4 |
5.108800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1856999999903E-05 |
| Normal-vs-AfricanAmerican |
1.798830E-03 |
| Normal-vs-Asian |
1.372160E-01 |
| Caucasian-vs-AfricanAmerican |
6.452800E-01 |
| Caucasian-vs-Asian |
1.254760E-01 |
| AfricanAmerican-vs-Asian |
1.281830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80589999999592E-05 |
| Normal-vs-Female |
7.67460000000719E-05 |
| Male-vs-Female |
2.918000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.247810E-02 |
| Normal-vs-Age(41-60Yrs) |
5.59559999999681E-05 |
| Normal-vs-Age(61-80Yrs) |
2.04329999997643E-06 |
| Normal-vs-Age(81-100Yrs) |
1.244020E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.476300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.800500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.680500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.450190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.112850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.366000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.869400E-01 |
| Classical-VS-Follicular |
1.003890E-02 |
| Classical-VS-Other |
4.810800E-01 |
| Classical-VS-Normal |
1.544240E-03 |
| Tall-VS-Follicular |
1.683960E-01 |
| Tall-VS-Other |
5.802400E-01 |
| Tall-VS-Normal |
6.104000E-02 |
| Follicular-VS-Other |
8.130600E-01 |
| Follicular-VS-Normal |
4.6335000000175E-06 |
| Other-VS-Normal |
3.050300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.45670000001519E-06 |
| Normal-vs-N1 |
1.322700E-03 |
| N0-vs-N1 |
6.160800E-01 |
|
|
